Alcohol on Ozempic, Wegovy, Zepbound or Mounjaro: What the Evidence Says

The US labels for Ozempic, Wegovy, Mounjaro and Zepbound don’t forbid alcohol. In fact, they don’t talk about drinking at all^[1,2,3,4]. Two of their warnings still matter if you drink. One is low blood sugar (hypoglycemia) when the medication is combined with insulin or a sulfonylurea^[1,2,3,4]. The other is acute pancreatitis, an inflammation of the pancreas, and heavy alcohol use is one of its most common causes^[8]. Early studies suggest semaglutide may reduce the urge to drink, but that isn’t an approved use^[11,15]. How alcohol fits with your treatment is a conversation to have with your doctor.

On October 5, 2026, I went through the current US prescribing information and Medication Guides on DailyMed for Ozempic and Mounjaro, approved for type 2 diabetes, and Wegovy and Zepbound, approved for weight management. I also checked the EU prescribing information where it differs, the published studies on alcohol and US public health guidance. Ozempic and Wegovy are semaglutide; Mounjaro and Zepbound are tirzepatide. The full eating plan is in what to eat on GLP-1 medications.

What the US labels say about alcohol

None of them mentions drinking

I searched the full text of all four labels, including the Medication Guides and the Instructions for Use. In the Ozempic label, the word “alcohol” only appears in the alcohol swab or wipe used to clean the injection site^[1]. The Wegovy label adds “nonalcoholic steatohepatitis,” the former name of the liver disease now called MASH, which Wegovy is approved to treat^[2]. In the Mounjaro and Zepbound labels, benzyl alcohol is an inactive ingredient of the multi-dose vial and the KwikPen^[3,4].

None describes an interaction with drinking or sets a limit. The EU prescribing information is silent too: alcohol only shows up as benzyl alcohol in the Mounjaro KwikPen^[5,6,7]. That silence doesn’t make alcohol irrelevant, though.

Low blood sugar if you also use insulin or a sulfonylurea

The Ozempic and Mounjaro labels say that people using them with insulin or an insulin secretagogue, such as a sulfonylurea (a group of type 2 diabetes medicines), may have an increased risk of hypoglycemia, including severe hypoglycemia^[1,3]. The labels for the weight-management versions go a step further:

• Wegovy: “WEGOVY lowers blood glucose and can cause hypoglycemia.” In a trial in adults with type 2 diabetes, hypoglycemia was reported in more people on Wegovy than on placebo^[2].
• Zepbound: in a trial in adults with type 2 diabetes, hypoglycemia (blood glucose under 54 mg/dL) affected 4.2% on Zepbound vs. 1.3% on placebo; among people on Zepbound, 10.3% of those also taking a sulfonylurea vs. 2.1% of those who weren’t. The label adds that hypoglycemia has also been associated with Zepbound in adults without type 2 diabetes^[4].

Alcohol is a separate risk factor. According to the NIDDK, the NIH institute for diabetes and digestive diseases, alcohol makes it harder for your body to keep blood glucose steady, especially if you haven’t eaten in a while. It can also keep you from feeling the first symptoms of a low^[10]. That’s why the NIDDK considers it safer to eat some food at the same time if you drink^[10].

The Medication Guides of all four list the signs of low blood sugar, among them dizziness or light-headedness, sweating, shakiness, confusion or drowsiness, slurred speech and a fast heartbeat^[1,2,3,4]. If you use insulin or a sulfonylurea, ask your doctor how alcohol fits with your treatment.

Pancreatitis: where alcohol matters most

All four US labels carry the same warning: acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, has been observed in patients treated with GLP-1 receptor agonists^[1,2,3,4]. These are the trial figures they report:

Here the US and EU labels differ. The EU prescribing information for Wegovy and Ozempic asks for caution in people with a history of pancreatitis, and the one for Mounjaro says tirzepatide hasn’t been studied in them and should be used with caution^[5,6,7]. The US prescribing information has no specific caution for a history of pancreatitis, but all four Medication Guides ask you to tell your healthcare provider if you “have or have had problems with your pancreas”^[1,2,3,4]. The EU information for Wegovy also reports the SELECT cardiovascular trial: 0.2% on semaglutide vs. 0.3% on placebo^[5].

According to the NIDDK, the most common causes of both acute and chronic pancreatitis are gallstones, heavy alcohol use, genetic disorders of the pancreas and some medicines^[8]. Neither the labels nor the NIDDK put a number on how the medication and alcohol combine.

The Medication Guides describe the warning sign and what to do about it. This is the wording of the Zepbound guide; the other three say nearly the same: “Stop using ZEPBOUND and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. Sometimes you may feel the pain from your abdomen to your back.”^[1,2,3,4]

Do GLP-1 medications reduce the urge to drink?

Reports from people on semaglutide who felt less like drinking sparked research interest, according to Wang and colleagues^[13]. The authors of the 2025 joint advisory on nutrition and GLP-1 therapy also say they’ve seen cravings for alcohol diminish in their clinical practice^[15]. This is what the studies have measured:

In the Hendershot trial, the grams of alcohol consumed in the lab fell with a β coefficient of −0.48 (95% CI, −0.85 to −0.11), a medium to large effect according to the authors. Drinks per drinking day fell with a β of −0.41, and craving with a β of −0.39^[11]. The authors acknowledge the limits: a small sample, few weeks and low doses^[11]. The cohort studies show an association, not cause and effect.

These are early findings that justify larger trials. Treating alcohol use isn’t among the approved uses in any of the four US labels^[1,2,3,4].

Calories, an empty stomach, nausea and sleep

Energy without protein. Under the EU food-labeling rules, each gram of alcohol counts as 7 kcal, vs. 4 for carbohydrates and protein^[21]. In 80-proof spirits, nearly all of the 231 kcal per 100 g come from their 33.4 g of alcohol, according to FoodData Central^[24]. When your appetite is small, the 2025 advisory puts protein first^[15], and alcohol takes up room without adding any. I explain it in protein and muscle on GLP-1 medications, and how to keep an eye on intake without obsessing in do I have to count calories on Ozempic?.

An empty stomach. GLP-1 medications reduce energy intake by 16% to 39% compared with placebo, according to the advisory^[15]. So it’s easier to end up drinking with little food in you, the situation the NIDDK flags for low blood sugar^[10]. All four labels also say the medications delay gastric emptying; for tirzepatide, the delay is largest after the first dose and diminishes over time^[1,2,3,4]. None of them says how that affects the absorption of alcohol, and I haven’t found that figure in official sources.

Nausea and reflux. According to the NIAAA, the NIH institute on alcohol, alcohol irritates the lining of the stomach and increases acid release, which can cause nausea^[20]. The 2025 advisory adds that alcohol may worsen nausea and reflux on GLP-1 therapy and should be minimized^[15]. More ideas in nausea on GLP-1 medications: what to eat and acid reflux on GLP-1 medications.

Dehydration. Alcohol suppresses vasopressin, the hormone that tells the kidneys to hold on to water, so you urinate more, the NIAAA explains^[20]. The Medication Guides warn that diarrhea, nausea and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems^[1,2,3,4]. Those are two fluid losses that add up. I cover how much to drink, and what, in hydration on GLP-1 medications.

Sleep. According to the NIAAA, people may fall asleep faster after drinking, but their sleep is fragmented and they tend to wake up earlier, which leaves them more tired the next day^[20]. Poor sleep also affects appetite, as I explain in sleep, stress and appetite.

Alcohol and calories per drink

In the US, a standard drink contains 14 g (0.6 fl oz) of pure alcohol. The single-drink sizes are the NIAAA’s^[17]; the larger servings and all the calories are my own calculation.

How I calculated it: grams of alcohol (volume × strength × 0.789 g/ml, the density of ethanol) times 7 kcal, plus carbohydrates and protein times 4 kcal^[21], using the per-100 g values in FoodData Central for beer, red wine, spirits and cola, and taking 1 ml as 1 g^{[22,23,24,25]}. These are rough figures: the real strength and the size of the glass change the math. Sweet mixers add sugar on top; if that’s what you reach for, I have ideas in sweet cravings on Ozempic or Mounjaro.

What US guidance considers too much

The NIAAA uses these definitions^[18]:

• Binge drinking: a pattern that brings blood alcohol concentration to 0.08% or higher. For a typical adult, that’s 5 or more drinks for men, or 4 or more for women, in about 2 hours.
• Heavy drinking: for men, 5 or more drinks on any day or 15 or more per week; for women, 4 or more on any day or 8 or more per week.

The Dietary Guidelines for Americans, 2025–2030 say to “consume less alcohol for better overall health” and give no daily number of drinks^[16]. The NIAAA notes that harms may be associated with any amount of drinking, and that harm increases as the amount does^[18]. The WHO Regional Office for Europe stated in 2023 that no level of alcohol consumption is safe for health^[19].

None of these definitions was written for people on GLP-1 medications, and none tells you how much is safe for you. If you have a party or a dinner out coming up, I go through the practical side in the holidays on Ozempic, Wegovy or Zepbound and eating out on GLP-1 medications.

When official sources advise not drinking

• Pancreatitis. The NIDDK says health care professionals strongly advise people with pancreatitis not to drink any alcohol, even if it’s mild^[9]. If you’ve had pancreatitis, bring it up with your doctor: the US Medication Guides ask you to mention any pancreas problems, and the EU labels ask for caution^{[1,2,3,4,5,6,7]}.
• Pregnancy, recovery from alcohol use disorder, or trouble controlling how much you drink. The Dietary Guidelines list these among the people who should avoid alcohol completely^[16].
• Some medicines and medical conditions. The Dietary Guidelines also include people taking medications or with medical conditions that can interact with alcohol, without naming which^[16]. If you take other medicines, ask your doctor or pharmacist.
• A family history of alcoholism. Here the guidelines ask you to be mindful of how much you drink^[16].
• When drinking is already causing problems. Your doctor can help you figure out next steps.

Frequently asked questions

Can you drink alcohol on Ozempic, Wegovy, Zepbound or Mounjaro?

None of the four US labels mentions drinking or forbids it^[1,2,3,4]. The answer still depends on you: a history of pancreatitis, whether you use insulin or a sulfonylurea, and how well you tolerate treatment. It’s an individual decision to make with your doctor.

Does alcohol make semaglutide or tirzepatide work less well?

The labels don’t describe any interaction with alcohol^[1,2,3,4], and I haven’t found studies that measure that effect. What is known is that alcohol provides 7 kcal per gram^[21] and may worsen nausea and reflux^[15].

How long after the injection should I wait to drink?

The labels don’t set any interval between the injection and a drink^[1,2,3,4]. If you have questions about your own situation, ask your doctor.

Why do I feel like drinking less since I started treatment?

Patients and doctors describe it^[13,15], and the first studies (in the table above) point that way^[11,13,14]. It isn’t yet known whether the effect lasts or who benefits most.

Can Ozempic or Wegovy be used to quit drinking?

It isn’t an approved use: Ozempic is approved for type 2 diabetes and Wegovy for weight management, among other uses, and none of the four labels includes alcohol use^[1,2,3,4]. The studies are early, and their authors call for larger trials^[11]. If you want to drink less, your doctor can help. I explain how these medications work in what are GLP-1 medications, and each active ingredient in my semaglutide guide and tirzepatide guide.